Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
163,800
-2,200 (-1.33%)
Jul 16, 2025, 3:30 PM KST
-17.27%
Market Cap3.81T
Revenue (ttm)213.08B
Net Income (ttm)-11.58B
Shares Out23.26M
EPS (ttm)-500.32
PE Ration/a
Forward PEn/a
Dividend200.00 (0.12%)
Ex-Dividend Daten/a
Volume90,160
Average Volume196,025
Open164,700
Previous Close166,000
Day's Range161,500 - 166,600
52-Week Range88,200 - 229,500
Beta1.76
RSI58.69
Earnings DateAug 13, 2025

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1943
Employees 410
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

In 2024, Sam Chun Dang Pharm.'s revenue was 210.92 billion, an increase of 9.47% compared to the previous year's 192.67 billion. Losses were -10.92 billion, 5.14% more than in 2023.

Financial Statements

News

There is no news available yet.